Literature DB >> 8988821

Pre-emptive analgesia with ketamine, morphine and epidural lidocaine prior to total knee replacement.

C S Wong1, C C Lu, C H Cherng, S T Ho.   

Abstract

PURPOSE: Pre-emptive analgesia can improve postoperative pain management. The purpose of this study was to examine the effectiveness of ketamine as a pre-emptive analgesic as previous studies have shown the involvement of N-methyl-D-Aspartate (NMDA) receptor in neuroplasticity.
METHODS: Forty-five ASA 1-2 patients, undergoing unilateral total knee replacement were studied. In the study groups, epidural lidocaine was used as the primary anaesthestic. Patients received ketamine + morphine epidurally 30 min either before (group EB) or after skin incision (group EA). Group G patients received general anaesthesia and ketamine + morphine were given 30 min after skin incision via an epidural catheter used for postoperative pain control. Epidural morphine and ketamine in lidocaine was given to all patients at the end of surgery and every 12 hr for three days for analgesia supplemented with PCA morphine. The time until first PCA trigger, morphine consumption, pain scores, satisfaction scores, and morphine related side effects were recorded at 6, 12, 24, 48 and 72 hr after surgery.
RESULTS: Epidural ketamine plus morphine with lidocaine before surgical incision produced better pain relief and patient satisfaction than when given after incision. A longer time to PCA and decreased morphine consumption were observed in group EB than in group G. In group EA, epidural anaesthesia also produced some pre-emptive analgesic effect compared with general anaesthesia shown by decreased morphine consumption.
CONCLUSIONS: Administration of ketamine plus morphine with epidural lidocaine anesthesia before surgery provided improved postoperative analgesia compared with general anaesthesia alone or when analgesics were given after skin incision.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8988821     DOI: 10.1007/BF03014321

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  8 in total

1.  Preemptive effects of a combination of preoperative diclofenac, butorphanol, and lidocaine on postoperative pain management following orthognathic surgery.

Authors:  C Nagatsuka; T Ichinohe; Y Kaneko
Journal:  Anesth Prog       Date:  2000

2.  The Epidural and Intrathecal Administration of Ketamine.

Authors: 
Journal:  Curr Rev Pain       Date:  1999

3.  The role of intraoperative interventions to minimise chronic postsurgical pain.

Authors:  Sibtain Anwar; Ben O'Brien
Journal:  Br J Pain       Date:  2017-07-18

4.  A comparative study of two different doses of epidural neostigmine coadministered with lignocaine for post operative analgesia and sedation.

Authors:  Mamta Harjai; Girish Chandra; V K Bhatia; Dinesh Singh; Priyesh Bhaskar
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2010-10

5.  Pre-emptive treatment of lidocaine attenuates neuropathic pain and reduces pain-related biochemical markers in the rat cuneate nucleus in median nerve chronic constriction injury model.

Authors:  Chi-Te Lin; Yi-Ju Tsai; Hsin-Ying Wang; Seu-Hwa Chen; Tzu-Yu Lin; June-Horng Lue
Journal:  Anesthesiol Res Pract       Date:  2011-11-24

6.  Quality of post-operative analgesia after epidural dexmedetomidine and ketamine: A comparative pilot study.

Authors:  Nilesh Balu Sonawane; J Balavenkatasubramanian; P Gurumoorthi; Poonam Ashok Jadhav
Journal:  Indian J Anaesth       Date:  2016-10

7.  Analgesic effects of intravenous ketamine after spinal anaesthesia for non-elective caesarean delivery: a randomised controlled trial.

Authors:  Prahlad Adhikari; Asish Subedi; Birendra Prasad Sah; Krishna Pokharel
Journal:  BMJ Open       Date:  2021-06-30       Impact factor: 2.692

8.  Effectiveness of adding ketamine to ropivacaine infusion via femoral nerve catheter after knee anterior cruciate ligament repair.

Authors:  Poupak Rahimzadeh; Seyed Hamid Reza Faiz; Mohsen Ziyaeifard; Keyvan Niknam
Journal:  J Res Med Sci       Date:  2013-08       Impact factor: 1.852

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.